Literature DB >> 11682144

Group I metabotropic glutamate receptors control phosphorylation of CREB, Elk-1 and ERK via a CaMKII-dependent pathway in rat striatum.

E S Choe1, J Q Wang.   

Abstract

In vivo activation of group I metabotropic glutamate receptors (mGluRs) upregulates phosphorylation of cyclic AMP response element-binding protein (CREB), Elk-1 and extracellular signal-regulated kinases (ERK) in striatal neurons. To evaluate putative roles of Ca2+/calmodulin-dependent protein kinase II (CaMKII) in CREB, Elk-1 and ERK phosphorylation, the CaMKII inhibitor, KN62, was infused simultaneously with the group I mGluR agonist, 3,5-dihydroxyphenylglycine (DHPG), into the rat dorsal striatum. The results showed that DHPG (125, 250, and 500 nmol) increased phosphorylated (p) CaMKII immunoreactivity (IR) in a dose-dependent manner. KN62 (50 nmol) significantly attenuated 500 nmol DHPG-induced pERK, pElk-1 and pCREB IR in the ipsilateral dorsal striatum. These data indicate that pCaMKII is a possible upstream effector that is responsible for the regulation of CREB, Elk-1 and ERK phosphoproteins in response to group I mGluR stimulation in striatal neurons.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682144     DOI: 10.1016/s0304-3940(01)02258-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  24 in total

1.  Hypobaric Preconditioning Modifies Group I mGluRs Signaling in Brain Cortex.

Authors:  Dmitry G Semenov; Alexandr V Belyakov; Tatjana S Glushchenko; Mikhail O Samoilov; Elzbieta Salinska; Jerzy W Lazarewicz
Journal:  Neurochem Res       Date:  2015-08-29       Impact factor: 3.996

2.  Regulation of extracellular signal-regulated kinase phosphorylation in cultured rat striatal neurons.

Authors:  Li-Min Mao; Qing-Song Tang; John Q Wang
Journal:  Brain Res Bull       Date:  2008-12-03       Impact factor: 4.077

3.  Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling.

Authors:  Akinori Nishi; Feng Liu; Seiichiro Matsuyama; Miho Hamada; Hideho Higashi; Angus C Nairn; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

4.  Phosphorylation and feedback regulation of metabotropic glutamate receptor 1 by calcium/calmodulin-dependent protein kinase II.

Authors:  Dao-Zhong Jin; Ming-Lei Guo; Bing Xue; Eugene E Fibuch; Eun Sang Choe; Li-Min Mao; John Q Wang
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

5.  Transcriptional profiling of the rat frontal cortex following administration of the mGlu5 receptor antagonists MPEP and MTEP.

Authors:  Justin T Gass; M Foster Olive
Journal:  Eur J Pharmacol       Date:  2008-02-20       Impact factor: 4.432

6.  Metabotropic glutamate receptor 5 upregulates surface NMDA receptor expression in striatal neurons via CaMKII.

Authors:  Dao-Zhong Jin; Bing Xue; Li-Min Mao; John Q Wang
Journal:  Brain Res       Date:  2015-08-06       Impact factor: 3.252

7.  Phosphorylation and regulation of glutamate receptors by CaMKII.

Authors:  Li-Min Mao; Dao-Zhong Jin; Bing Xue; Xiang-Ping Chu; John Q Wang
Journal:  Sheng Li Xue Bao       Date:  2014-06-25

Review 8.  Group I metabotropic glutamate receptor-mediated gene expression in striatal neurons.

Authors:  Li-Min Mao; Guo-Chi Zhang; Xian-Yu Liu; Eugene E Fibuch; John Q Wang
Journal:  Neurochem Res       Date:  2008-03-20       Impact factor: 3.996

9.  Protein kinase C-regulated cAMP response element-binding protein phosphorylation in cultured rat striatal neurons.

Authors:  Li-Min Mao; Qingsong Tang; John Q Wang
Journal:  Brain Res Bull       Date:  2007-01-31       Impact factor: 4.077

10.  Cue-induced reinstatement of alcohol-seeking behavior is associated with increased ERK1/2 phosphorylation in specific limbic brain regions: blockade by the mGluR5 antagonist MPEP.

Authors:  Jason P Schroeder; Marina Spanos; Jennie R Stevenson; Joyce Besheer; Michael Salling; Clyde W Hodge
Journal:  Neuropharmacology       Date:  2008-07-04       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.